To conceive, design, test, and prepare the ecosystem for fundamentally novel platform technologies with breakthrough potential in service of the foundation’s global health mission.
Anton Van Leeuwenhoek's first microscope.Credit: Getty Images
As the foundation’s technology innovation team, we believe that positive future outcomes in global health require reimagining the paradigms and platforms available today. To do this, we conceive, design, test, and position fundamentally novel technologies for impact in service of the foundation’s mission.
Strategy leadership
Dan Wattendorf
Director, Accelerator
Dan Wattendorf leads the Accelerator program, including its Activator unit, which focuses on exploring, testing, and creating new concepts and technologies and activating private-sector entities to advance these new solutions.
Jennifer Weisman
Head of Partnerships, Accelerator
Jenni Weisman leads a team that scopes out new program areas for development and builds external collaborations. Her role also includes leading internal business operations and portfolio management for the Accelerator.
Mike McCune
Head of HIV Frontiers, Accelerator
Mike McCune leads a team that works to develop novel gene-based curative interventions for HIV and sickle cell disease.
Skip Virgin
Head of AI-enabled Cures Frontiers, Accelerator
Skip Virgin leads a team that works to develop novel, AI-enabled approaches to drug discovery for curative interventions to virally induced chronic diseases.
Michael Reilly
Head of Business Innovation, Accelerator
Mike Reilly supports partner companies to ensure that the capabilities advanced by the Accelerator lead to broad societal benefit.
Sign up for The Optimist newsletter
Subscribe to The Optimist to get weekly updates on the latest in global health, gender equality, education, and more.
